These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pediatric Patient Blood Management Programs: Not Just Transfusing Little Adults. Goel R; Cushing MM; Tobian AA Transfus Med Rev; 2016 Oct; 30(4):235-41. PubMed ID: 27559005 [TBL] [Abstract][Full Text] [Related]
3. New Approaches and Trials in Pediatric Transfusion Medicine. Jacquot C; Mo YD; Luban NLC Hematol Oncol Clin North Am; 2019 Jun; 33(3):507-520. PubMed ID: 31030816 [TBL] [Abstract][Full Text] [Related]
4. Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG. te Pas AB; Lopriore E; van den Akker ES; Oepkes D; Kanhai HH; Brand A; Walther FJ Eur J Pediatr; 2007 Oct; 166(10):1057-63. PubMed ID: 17177068 [TBL] [Abstract][Full Text] [Related]
5. Neonatal Platelet Transfusions and Future Areas of Research. Sola-Visner M; Bercovitz RS Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660 [TBL] [Abstract][Full Text] [Related]
6. Pathogen-reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions. Lasky B; Nolasco J; Graff J; Ward DC; Ziman A; McGonigle AM Transfusion; 2021 Oct; 61(10):2869-2876. PubMed ID: 34448199 [TBL] [Abstract][Full Text] [Related]
7. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion. Pasion JO; Song LH; McCusker MG; Shimer L; Bryant A; McGann HL; Fontaine MJ Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569 [TBL] [Abstract][Full Text] [Related]
8. Age of platelet concentrates and time to the next transfusion. Caram-Deelder C; van der Bom JG; Putter H; Leyte A; Kerkhof DV; Evers D; Beckers EA; Weerkamp F; Hudig F; Zwaginga JJ; Rondeel JMM; de Vooght KMK; Péquériaux NCV; Visser O; Wallis JP; Middelburg RA Transfusion; 2018 Jan; 58(1):121-131. PubMed ID: 29090466 [TBL] [Abstract][Full Text] [Related]
9. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Osselaer JC; Messe N; Hervig T; Bueno J; Castro E; Espinosa A; Accorsi P; Junge K; Jacquet M; Flament J; Corash L Transfusion; 2008 Jun; 48(6):1061-71. PubMed ID: 18346019 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pathogen-reduced platelet concentrates in children with cancer: a retrospective cohort study. Trakhtman P; Karpova O; Balashov D; Kurnikova E; Pirumova V; Starostin N; Rumiantsev A Transfusion; 2016 Mar; 56 Suppl 1():S24-8. PubMed ID: 27001357 [TBL] [Abstract][Full Text] [Related]
11. Determination Thuku NW; Shikuku K; Mbugua A Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628 [TBL] [Abstract][Full Text] [Related]
16. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody. Xu X; Li L; Xia W; Ding H; Chen D; Liu J; Deng J; Chen Y; He Z; Wang J; Shao Y; Santoso S; Ye X; Fang Q Int J Hematol; 2018 Feb; 107(2):251-256. PubMed ID: 28815406 [TBL] [Abstract][Full Text] [Related]
17. Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin. Bakchoul T; Bassler D; Heckmann M; Thiele T; Kiefel V; Gross I; Arnold DM; DiTomasso J; Smith JW; Paes B; Greinacher A Transfusion; 2014 Mar; 54(3):640-5. PubMed ID: 23869512 [TBL] [Abstract][Full Text] [Related]
18. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility. Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341 [TBL] [Abstract][Full Text] [Related]
19. Neonatal Transfusion Practice: When do Neonates Need Red Blood Cells or Platelets? Del Vecchio A; Franco C; Petrillo F; D'Amato G Am J Perinatol; 2016 Sep; 33(11):1079-84. PubMed ID: 27603540 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]